Needham & Company Starts Galena Biopharma (GALE) at Buy
Tweet Send to a Friend
Needham & Company initiates coverage on Galena Biopharma (NASDAQ: GALE) with a Buy. PT $3.50.
Analyst Chad Messer comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst Chad Messer comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE